InvestorsHub Logo
Followers 2
Posts 180
Boards Moderated 0
Alias Born 06/19/2014

Re: None

Friday, 01/15/2016 11:22:56 AM

Friday, January 15, 2016 11:22:56 AM

Post# of 1856
Phase 2b MONARCH combination study of ARC-520 has begun human trials of it's RNAi-based drug for the treatment of chronic hepatitis B virus (HBV) infection.
IMA a cure for Hepatitis B, 6.5 K @ 4.48
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARWR News